These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38095411)

  • 1. Oxygen-ozone autohemotherapy in breast cancer patients suffering from fatigue and musculoskeletal pain upon aromatase inhibitors treatment: a case-series study.
    Tirelli U; Valdenassi L; Franzini M; Pandolfi S; Fisichella R; Chirumbolo S
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11643-11652. PubMed ID: 38095411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy - preliminary results on 100 patients.
    Tirelli U; Franzini M; Valdenassi L; Pisconti S; Taibi R; Torrisi C; Pandolfi S; Chirumbolo S
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5871-5875. PubMed ID: 34604980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibromyalgia treated with oxygen-ozone auto-haemotherapy (O2-O3-AHT): a case study on 200 patients with a modified 10-PI-NRS evaluation.
    Tirelli U; Franzini M; Valdenassi L; Pandolfi S; Taibi R; Chirumbolo S
    Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):7974-7979. PubMed ID: 36394747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
    Roberts KE; Rickett K; Feng S; Vagenas D; Woodward NE
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012988. PubMed ID: 31994181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
    Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors and musculoskeletal pain in patients with breast cancer.
    Winters L; Habin K; Gallagher J
    Clin J Oncol Nurs; 2007 Jun; 11(3):433-9. PubMed ID: 17623627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial.
    Mao JJ; Farrar JT; Bruner D; Zee J; Bowman M; Seluzicki C; DeMichele A; Xie SX
    Cancer; 2014 Dec; 120(23):3744-51. PubMed ID: 25077452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
    De Placido S; Gallo C; De Laurentiis M; Bisagni G; Arpino G; Sarobba MG; Riccardi F; Russo A; Del Mastro L; Cogoni AA; Cognetti F; Gori S; Foglietta J; Frassoldati A; Amoroso D; Laudadio L; Moscetti L; Montemurro F; Verusio C; Bernardo A; Lorusso V; Gravina A; Moretti G; Lauria R; Lai A; Mocerino C; Rizzo S; Nuzzo F; Carlini P; Perrone F;
    Lancet Oncol; 2018 Apr; 19(4):474-485. PubMed ID: 29482983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study.
    Briot K; Tubiana-Hulin M; Bastit L; Kloos I; Roux C
    Breast Cancer Res Treat; 2010 Feb; 120(1):127-34. PubMed ID: 20035381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ozone therapy in 65 patients with fibromyalgia: an effective therapy.
    Tirelli U; Cirrito C; Pavanello M; Piasentin C; Lleshi A; Taibi R
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1786-1788. PubMed ID: 30840304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.
    Martínez N; Herrera M; Frías L; Provencio M; Pérez-Carrión R; Díaz V; Morse M; Crespo MC
    Clin Transl Oncol; 2019 Apr; 21(4):489-498. PubMed ID: 30293230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Campbell A; Heydarian R; Ochoa C; Dwivedi AK; Nahleh ZA
    Breast J; 2018 May; 24(3):260-268. PubMed ID: 29442401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.
    Morales L; Neven P; Timmerman D; Christiaens MR; Vergote I; Van Limbergen E; Carbonez A; Van Huffel S; Ameye L; Paridaens R
    Anticancer Drugs; 2004 Sep; 15(8):753-60. PubMed ID: 15494636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI.
    Lintermans A; Van Asten K; Wildiers H; Laenen A; Paridaens R; Weltens C; Verhaeghe J; Vanderschueren D; Smeets A; Van Limbergen E; Leunen K; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2014 Jul; 146(1):109-16. PubMed ID: 24816806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early Breast cancer: A systematic review and meta-analysis.
    Roberts K; Rickett K; Greer R; Woodward N
    Crit Rev Oncol Hematol; 2017 Mar; 111():66-80. PubMed ID: 28259297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: A randomized, controlled clinical trial.
    Peng N; Yu M; Yang G; Fu Q; Xu Y; Yu J; Liu Q; Li C; Xu W; Zhang Y; Ma C; Yang L; Yu R; Wang X
    Breast; 2018 Feb; 37():18-27. PubMed ID: 29059538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy.
    Tirelli U; Franzini M; Valdenassi L; Pandolfi S; Berretta M; Ricevuti G; Chirumbolo S
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study.
    Singer O; Cigler T; Moore AB; Levine AB; Hentel K; Belfi L; Do HT; Mandl LA
    Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1910-8. PubMed ID: 22730307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors.
    Olufade T; Gallicchio L; MacDonald R; Helzlsouer KJ
    Support Care Cancer; 2015 Feb; 23(2):447-55. PubMed ID: 25128067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer.
    Gallicchio L; MacDonald R; Helzlsouer KJ
    J Cancer Res Clin Oncol; 2013 May; 139(5):837-43. PubMed ID: 23408333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.